Literature DB >> 9917287

Loloatins A-D, cyclic decapeptide antibiotics produced in culture by a tropical marine bacterium.

J M Gerard1, P Haden, M T Kelly, R J Andersen.   

Abstract

Loloatins A (1) to D (4), a family of new cyclic decapeptide antibiotics, have been isolated from laboratory cultures of a tropical marine bacterium recovered from the Great Barrier Reef in Papua New Guinea. The structures of loloatins A-D were elucidated via a combination of spectroscopic analyses and chemical degradation. Loloatins A-D exhibit in vitro antimicrobial activity against methicillin-resistant Staphyloccoccus aureus, vancomycin-resistant enterococci, and drug-resistant Streptococcus pneumoniae.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 9917287     DOI: 10.1021/np980219f

Source DB:  PubMed          Journal:  J Nat Prod        ISSN: 0163-3864            Impact factor:   4.050


  14 in total

Review 1.  Development of antibiotics and the future of marine microorganisms to stem the tide of antibiotic resistance.

Authors:  Noer Kasanah; Mark T Hamann
Journal:  Curr Opin Investig Drugs       Date:  2004-08

2.  Genome sequence of Brevibacillus laterosporus LMG 15441, a pathogen of invertebrates.

Authors:  Marvin Djukic; Anja Poehlein; Andrea Thürmer; Rolf Daniel
Journal:  J Bacteriol       Date:  2011-10       Impact factor: 3.490

Review 3.  Marine natural product peptides with therapeutic potential: Chemistry, biosynthesis, and pharmacology.

Authors:  Vedanjali Gogineni; Mark T Hamann
Journal:  Biochim Biophys Acta Gen Subj       Date:  2017-08-24       Impact factor: 3.770

Review 4.  Antimicrobial peptides produced by Brevibacillus spp.: structure, classification and bioactivity: a mini review.

Authors:  Xu Yang; Ahmed E Yousef
Journal:  World J Microbiol Biotechnol       Date:  2018-03-29       Impact factor: 3.312

5.  Brevilaterin B from Brevibacillus laterosporus has selective antitumor activity and induces apoptosis in epidermal cancer.

Authors:  Zhou Chen; Lulu Wang; Yangliu Liu; Panpan Han; Dan Hong; Siting Li; Aijin Ma; Yingmin Jia
Journal:  World J Microbiol Biotechnol       Date:  2022-08-24       Impact factor: 4.253

Review 6.  Marine Cyclic Peptides: Antimicrobial Activity and Synthetic Strategies.

Authors:  Ricardo Ribeiro; Eugénia Pinto; Carla Fernandes; Emília Sousa
Journal:  Mar Drugs       Date:  2022-06-15       Impact factor: 6.085

7.  Anti-methicillin Resistant Staphylococcus aureus Compound Isolation from Halophilic Bacillus amyloliquefaciens MHB1 and Determination of Its Mode of Action Using Electron Microscope and Flow Cytometry Analysis.

Authors:  Venkadapathi Jeyanthi; Palaniyandi Velusamy
Journal:  Indian J Microbiol       Date:  2016-01-30       Impact factor: 2.461

Review 8.  Novel anti-infective compounds from marine bacteria.

Authors:  Hafizur Rahman; Brian Austin; Wilfrid J Mitchell; Peter C Morris; Derek J Jamieson; David R Adams; Andrew Mearns Spragg; Michael Schweizer
Journal:  Mar Drugs       Date:  2010-03-05       Impact factor: 5.118

9.  Competitive induction and enhancement of indole and a diketopiperazine in marine bacteria.

Authors:  Jacqueline A Trischman; Richard E Oeffner; Michelle G de Luna; Martin Kazaoka
Journal:  Mar Biotechnol (NY)       Date:  2004-05-13       Impact factor: 3.619

10.  MC21-A, a bactericidal antibiotic produced by a new marine bacterium, Pseudoalteromonas phenolica sp. nov. O-BC30(T), against methicillin-resistant Staphylococcus aureus.

Authors:  Alim Isnansetyo; Yuto Kamei
Journal:  Antimicrob Agents Chemother       Date:  2003-02       Impact factor: 5.191

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.